PD‐L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B‐cell lymphoma treated with rituximab‐based multi‐agent chemotherapy
出版年份 2020 全文链接
标题
PD‐L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B‐cell lymphoma treated with rituximab‐based multi‐agent chemotherapy
作者
关键词
-
出版物
Cancer Medicine
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-05-05
DOI
10.1002/cam4.3104
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Incisional random skin biopsy, not punch biopsy, is an appropriate method for diagnosis of intravascular large B-cell lymphoma: A clinicopathological study of 25 patients
- (2019) N Enzan et al. BRITISH JOURNAL OF DERMATOLOGY
- PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program
- (2019) Ling Li et al. MODERN PATHOLOGY
- Immune evasion-related extranodal large B-cell lymphoma: A report of six patients with neoplastic PD-L1-positive extranodal diffuse large B-cell lymphoma
- (2019) Yuka Suzuki et al. PATHOLOGY INTERNATIONAL
- Divergence and heterogeneity of neoplastic PD-L1 expression: Two autopsy case reports of intravascular large B-cell lymphoma
- (2019) Ayako Sakakibara et al. PATHOLOGY INTERNATIONAL
- PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B cell diffuse large B-cell lymphomas
- (2019) Marién Pascual et al. BLOOD
- A Study of PD ‐L1 Expression in Intravascular Large B‐cell Lymphoma: Correlation with Clinical and Pathologic Features
- (2019) Gaurav K. Gupta et al. HISTOPATHOLOGY
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
- (2019) Tony S K Mok et al. LANCET
- Prognostic impact of PD-L1 expression in primary gastric and intestinal diffuse large B-cell lymphoma
- (2019) Eri Ishikawa et al. JOURNAL OF GASTROENTEROLOGY
- High prevalence ofMYD88andCD79Bmutations in intravascular large B-cell lymphoma
- (2018) Anne M. R. Schrader et al. BLOOD
- Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma
- (2018) Yosuke Tanaka et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Liquid biopsy for the identification of intravascular large B-cell lymphoma
- (2018) Yasuhito Suehara et al. HAEMATOLOGICA
- Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells
- (2018) Ayako Sakakibara et al. HISTOPATHOLOGY
- Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
- (2018) Margaretha G.M. Roemer et al. JOURNAL OF CLINICAL ONCOLOGY
- Liquid biopsy for the identification of intravascular large B-cell lymphoma
- (2018) Yasuhito Suehara et al. HAEMATOLOGICA
- Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
- (2018) Tammy Linlin Song et al. BLOOD
- PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma
- (2017) V Atsaves et al. LEUKEMIA
- Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies
- (2017) Cristina Ilcus et al. OncoTargets and Therapy
- PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma
- (2016) H. Miyoshi et al. BLOOD
- Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas
- (2016) K. Georgiou et al. BLOOD
- Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
- (2016) Alexander M. Lesokhin et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
- (2016) Margaretha G.M. Roemer et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma
- (2016) Xi-wen Bi et al. Journal of Hematology & Oncology
- Targetable genetic features of primary testicular and primary central nervous system lymphomas
- (2015) B. Chapuy et al. BLOOD
- Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma
- (2015) J. Kiyasu et al. BLOOD
- Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma
- (2015) Laurence Albiges et al. EUROPEAN JOURNAL OF CANCER
- PD-L1 expression and prognostic impact in glioblastoma
- (2015) Edjah K. Nduom et al. NEURO-ONCOLOGY
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-L1 expression in nonclear-cell renal cell carcinoma
- (2014) T. K. Choueiri et al. ANNALS OF ONCOLOGY
- PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
- (2013) B. J. Chen et al. CLINICAL CANCER RESEARCH
- Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphoma
- (2013) Elodie Bohers et al. GENES CHROMOSOMES & CANCER
- CD79B and MYD88 mutations in diffuse large B-cell lymphoma
- (2013) Yuil Kim et al. HUMAN PATHOLOGY
- High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites
- (2013) W Kraan et al. Blood Cancer Journal
- Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies
- (2012) Kian-Huat Lim et al. IMMUNOLOGICAL REVIEWS
- Programmed Death Ligand 1 Is Expressed by Non-Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells
- (2011) D. J. Andorsky et al. CLINICAL CANCER RESEARCH
- An autopsy case of lymphomatosis cerebri showing pathological changes of intravascular large B-cell lymphoma in visceral organs
- (2011) Nozomi Hishikawa et al. NEUROPATHOLOGY
- Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
- (2010) M. R. Green et al. BLOOD
- Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma
- (2010) Ryosuke Hino et al. CANCER
- Central nervous system involvement in intravascular large B-cell lymphoma: A retrospective analysis of 109 patients
- (2010) Kazuyuki Shimada et al. CANCER SCIENCE
- Oncogenically active MYD88 mutations in human lymphoma
- (2010) Vu N. Ngo et al. NATURE
- Presentation and management of intravascular large B-cell lymphoma
- (2009) Kazuyuki Shimada et al. LANCET ONCOLOGY
- Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma
- (2009) Hiroshi Imai et al. PATHOLOGY INTERNATIONAL
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Retrospective Analysis of Intravascular Large B-Cell Lymphoma Treated With Rituximab-Containing Chemotherapy As Reported by the IVL Study Group in Japan
- (2008) Kazuyuki Shimada et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started